Thiadiazoline derivative
    5.
    发明公开
    Thiadiazoline derivative 有权
    噻二唑啉衍生物zur Behandlung von Krebs

    公开(公告)号:EP1847534A2

    公开(公告)日:2007-10-24

    申请号:EP07015426.5

    申请日:2002-12-11

    摘要: (wherein R 1 and R 4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R 5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R 2 represents -C(=W)R 6 or the like; R 3 represents a hydrogen atom, -C(=W A )R 6A , or the like)
    Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.

    摘要翻译: (其中R 1和R 4相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的低级炔基,取代或未取代的低级链烯基等; R 5表示取代或未取代的杂环基 取代或未取代的芳基等; R 2表示-C(= W)R 6等; R 3表示氢原子,-C(= WA)R 6A等)抗肿瘤剂,其包含 提供由上述通式(I)表示的噻二唑啉衍生物或其药理学上可接受的盐作为有效成分。